Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)

Por Kuin, A, Rutgers, M, Valk, M A van der, Beijnen, J H, Smets, L A
Publicado em 1999

Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG)

Por Kuin, A, Aalders, M, Lamfers, M, Zuidam, D J van, Essers, M, Beijnen, J H, Smets, L A
Publicado em 1999